ÂÜÀòÂÒÂ×

Joel Turner is an experienced professional in market access within the pharmaceutical industry, currently serving as Vice President of US Market Access at BioCryst Pharmaceuticals, Inc. since January 2020. Prior to this role, Joel held key positions at Array BioPharma Inc. and Merrimack, where Joel led US Market Access initiatives. Joel's career includes roles at Millennium Pharmaceuticals, sanofi-aventis, and Celgene/Pharmion, focusing on market access and reimbursement strategies. Academic credentials include a Bachelor of Science in Marketing, Finance, and Information Technology from California State University, Fresno, and a Master of Business Administration from Meinders School of Business, Oklahoma City University.